Literature DB >> 11938803

[Chinese drugs for invigorating spleen to remove dampness, activating blood circulation to eliminate turbid in retarding progression of chronic renal failure].

Y Yu1, J Cui, F Zhang.   

Abstract

OBJECTIVE: To investigate the effect of Chinese drugs (CD) for invigorating Spleen to remove dampness, activating blood circulation to eliminate Turbid in retarding progression of chronic renal failure (CRF).
METHODS: Thirty-nine patients with CRF were divided into two groups randomly, 18 patients in the control group were treated with low protein diet and controlling blood pressure and 21 patients in the CD group were treated similarly with that of the control group but with additional CD. Levels of serum creatinine (SCr), blood urea nitrogen (BUN), blood albumin (Alb), cholesterol (CH), triglyceride (TG), high-density lipoprotein (HDL) and hemoglobin (Hb) were checked every 2 months, and the rate of progression of CRF was estimated by slope of the creatinine reciprocal (1/SCr) with time (month).
RESULTS: Levels of SCr and BUN in the CD group were significantly lower and HDL markedly higher than those in the control group, P < 0.05. Mean slopes of the creatinine reciprocal with time in the two groups was significantly different, P < 0.01.
CONCLUSION: Additional CD treatment based upon the protein diet and controlling blood pressure could retard the progression process of CRF evidently.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11938803

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Clinical study of Trilogy Detoxicating Therapy combined with routine Western medicine on patients with chronic renal failure.

Authors:  Xi-li Wu; Wan-sen Sun; Wang-gang Zhang; Cheng-lin Qiao; Run-xia Liu
Journal:  Chin J Integr Med       Date:  2008-08-06       Impact factor: 1.978

2.  Efficacy and safety of the Fu-Zheng-Qu-Zhuo method on retarding the progress of chronic kidney disease (stage 3-4): a systematic review and meta-analysis.

Authors:  Shi-Yi Liu; Po Huang; Ning Zhang
Journal:  Ann Transl Med       Date:  2019-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.